172 related articles for article (PubMed ID: 31963723)
1. Profiling the Structural Determinants of Aryl Benzamide Derivatives as Negative Allosteric Modulators of mGluR5 by In Silico Study.
Zhao Y; Chen J; Liu Q; Li Y
Molecules; 2020 Jan; 25(2):. PubMed ID: 31963723
[TBL] [Abstract][Full Text] [Related]
2. Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinity.
Anighoro A; Graziani D; Bettinelli I; Cilia A; De Toma C; Longhi M; Mangiarotti F; Menegon S; Pirona L; Poggesi E; Riva C; Rastelli G
Bioorg Med Chem; 2015 Jul; 23(13):3040-58. PubMed ID: 26014480
[TBL] [Abstract][Full Text] [Related]
3. Computer-aided design of negative allosteric modulators of metabotropic glutamate receptor 5 (mGluR5): Comparative molecular field analysis of aryl ether derivatives.
Selvam C; Thilagavathi R; Narasimhan B; Kumar P; Jordan BC; Ranganna K
Bioorg Med Chem Lett; 2016 Feb; 26(4):1140-4. PubMed ID: 26826734
[TBL] [Abstract][Full Text] [Related]
4. In silico profiling the interaction mechanism of 2,5-diketopiperazine derivatives as oxytocin antagonists.
Yang M; Luo J; Zeng Z; Yang L; Xu L; Li Y
J Mol Graph Model; 2019 Jun; 89():178-191. PubMed ID: 30904734
[TBL] [Abstract][Full Text] [Related]
5. Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors.
Fu TT; Tu G; Ping M; Zheng GX; Yang FY; Yang JY; Zhang Y; Yao XJ; Xue WW; Zhu F
Acta Pharmacol Sin; 2021 Aug; 42(8):1354-1367. PubMed ID: 33122823
[TBL] [Abstract][Full Text] [Related]
6. 7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5.
Topiol S; Sabio M
Bioorg Med Chem Lett; 2016 Jan; 26(2):484-494. PubMed ID: 26706173
[TBL] [Abstract][Full Text] [Related]
7. Atom-based 3D-QSAR, induced fit docking, and molecular dynamics simulations study of thieno[2,3-b]pyridines negative allosteric modulators of mGluR5.
Vijaya Prabhu S; Singh SK
J Recept Signal Transduct Res; 2018 Jun; 38(3):225-239. PubMed ID: 29806525
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Binding Mechanism of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators in Clinical Trials by Molecular Dynamics Simulations.
Fu T; Zheng G; Tu G; Yang F; Chen Y; Yao X; Li X; Xue W; Zhu F
ACS Chem Neurosci; 2018 Jun; 9(6):1492-1502. PubMed ID: 29522307
[TBL] [Abstract][Full Text] [Related]
9. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
10. Computational analysis of negative and positive allosteric modulator binding and function in metabotropic glutamate receptor 5 (in)activation.
Dalton JA; Gómez-Santacana X; Llebaria A; Giraldo J
J Chem Inf Model; 2014 May; 54(5):1476-87. PubMed ID: 24793143
[TBL] [Abstract][Full Text] [Related]
11. QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations Studies of Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Anticancer Agents.
Abdizadeh R; Heidarian E; Hadizadeh F; Abdizadeh T
Anticancer Agents Med Chem; 2021; 21(8):987-1018. PubMed ID: 32698753
[TBL] [Abstract][Full Text] [Related]
12. Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family.
Feng Z; Ma S; Hu G; Xie XQ
AAPS J; 2015 May; 17(3):737-53. PubMed ID: 25762450
[TBL] [Abstract][Full Text] [Related]
13. Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol.
Al Rawashdah S; Hamrouni A; Sadek B; Amer R; Metwaly M; Atatreh N; Ghattas MA
J Mol Graph Model; 2019 Nov; 92():44-54. PubMed ID: 31306865
[TBL] [Abstract][Full Text] [Related]
14. Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors.
Harvey BD; Siok CJ; Kiss T; Volfson D; Grimwood S; Shaffer CL; Hajós M
Neuropharmacology; 2013 Dec; 75():19-30. PubMed ID: 23831682
[TBL] [Abstract][Full Text] [Related]
15. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.
Dong L; Feng R; Bi J; Shen S; Lu H; Zhang J
J Mol Model; 2018 Mar; 24(4):86. PubMed ID: 29511885
[TBL] [Abstract][Full Text] [Related]
16. Mechanism Exploration of Arylpiperazine Derivatives Targeting the 5-HT
Lin F; Li F; Wang C; Wang J; Yang Y; Yang L; Li Y
Molecules; 2017 Jun; 22(7):. PubMed ID: 28672848
[TBL] [Abstract][Full Text] [Related]
17. Structural determination of three different series of compounds as Hsp90 inhibitors using 3D-QSAR modeling, molecular docking and molecular dynamics methods.
Liu J; Wang F; Ma Z; Wang X; Wang Y
Int J Mol Sci; 2011 Jan; 12(2):946-70. PubMed ID: 21541036
[TBL] [Abstract][Full Text] [Related]
18. Profiling the interaction mechanism of quinoline/quinazoline derivatives as MCHR1 antagonists: an in silico method.
Wu M; Li Y; Fu X; Wang J; Zhang S; Yang L
Int J Mol Sci; 2014 Sep; 15(9):15475-502. PubMed ID: 25257526
[TBL] [Abstract][Full Text] [Related]
19. Binding of a positive allosteric modulator CDPPB to metabotropic glutamate receptor type 5 (mGluR5) probed by all-atom molecular dynamics simulations.
Uba AI; Chea J; Hoag H; Hryb M; Bui-Linh C; Wu C
Life Sci; 2022 Nov; 309():121014. PubMed ID: 36179814
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization and modeling of the binding sites of novel 1,3-bis(pyridinylethynyl)benzenes as metabotropic glutamate receptor 5-selective negative allosteric modulators.
Mølck C; Harpsøe K; Gloriam DE; Clausen RP; Madsen U; Pedersen LØ; Jimenez HN; Nielsen SM; Mathiesen JM; Bräuner-Osborne H
Mol Pharmacol; 2012 Nov; 82(5):929-37. PubMed ID: 22899869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
